Ingalls & Snyder LLC Perkinelmer Inc Transaction History

Ingalls & Snyder LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$120.16 - $144.38 $27,276 - $32,774	-227 Reduced 11.83%	1,692 $225,000
Q4 2022 Jan 31, 2023	SELL	$119.0 - $147.98 $17,850 - $22,197	-150 Reduced 7.25%	1,919 $269,000
Q1 2022 May 09, 2022	BUY	$162.31 - $192.2 $1,947 - $2,306	12 Added 0.58%	2,069 $361,000
Q3 2021 Oct 27, 2021	SELL	$151.98 - $190.5 $43,922 - $55,054	-289 Reduced 12.32%	2,057 $356,000
Q2 2021 Aug 03, 2021	SELL	$127.81 - $155.84 $9,202 - $11,220	-72 Reduced 2.98%	2,346 $362,000
Q1 2021 Apr 21, 2021	SELL	$120.35 - $160.53 $3,730 - $4,976	-31 Reduced 1.27%	2,418 $310,000
Q4 2020 Jan 27, 2021	BUY	$122.05 - $147.91 $2,685 - $3,254	22 Added 0.91%	2,449 $351,000
Q3 2020 Oct 21, 2020	BUY	$97.09 - $125.51 $235,637 - $304,612	2,427 New	2,427 $305,000

575

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.